SmiNet-2: Description of an internet-based surveillance system for communicable diseases in Sweden.

SmiNet-2: Description of an internet-based surveillance system for communicable diseases in Sweden.
复制标题

DOI:
10.2807/esm.11.05.00626-en
复制
发表时间:
2006-05-01
期刊:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
影响因子:
--
通讯作者:
Ekdahl, K
Ekdahl, K
中科院分区:
其他
文献类型:
--
作者:
Rolfhamre, P;Janson, A;Ekdahl, K

文献摘要

被引文献

相似文献

传染病监测电子系统通过简化报告、提高完整性和及时性来提高质量。在本文中,我们概述了 SmiNet-2 背后的想法和技术,SmiNet-2 是瑞典新的综合性区域/国家传染病监测系统。该系统允许医生(网络表格)和实验室(直接来自实验室数据系统)通过互联网进行报告。 SmiNet-2 使用唯一的个人识别码,自动将临床和实验室通知合并到病例记录中。国家和县级的特权用户在包含所有通知和案例记录的公共中央服务器上工作。此外,SmiNet-2 还拥有独立的县级服务器,其中包含用于疫情调查、接触者追踪和病例管理的工具。 SmiNet-2 于 2004 年 9 月首次使用。各个县以电子方式收到高达 90% 的通知。第一年,SmiNet-2 收到了 54,980 份临床通知和 32,765 份实验室通知,生成了 58,891 条病例记录。由于瑞典的大多数临床医生可以轻松访问互联网,因此基于网络的通用报告是可行的,并且预计在几年内向 SmiNet-2 的所有报告都将通过互联网进行。在此背景下,与其他系统相比,SmiNet-2 的一些主要优势包括数据流的及时性(达到国家水平)、临床和实验室通知的全面整合,以及能够在一个系统内通过定制的通知表格处理 50 多种疾病。传染病监测电子系统通过简化报告、提高完整性和及时性来提高质量。在本文中,我们概述了 SmiNet-2 背后的想法和技术,SmiNet-2 是瑞典新的综合性区域/国家传染病监测系统。该系统允许医生(网络表格)和实验室(直接来自实验室数据系统)通过互联网进行报告。 SmiNet-2 使用唯一的个人识别码,自动将临床和实验室通知合并到病例记录中。国家和县级的特权用户在包含所有通知和案例记录的公共中央服务器上工作。此外,SmiNet-2 还拥有独立的县级服务器,其中包含用于疫情调查、接触者追踪和病例管理的工具。 SmiNet-2 于 2004 年 9 月首次使用。各个县以电子方式收到高达 90% 的通知。在第一年,SmiNet-2 收到了 54 980 份临床通知和 32 765 份实验室通知,生成了 58 891 条病例记录。由于瑞典的大多数临床医生可以轻松访问互联网,因此基于网络的通用报告是可行的,并且预计在几年内向 SmiNet-2 的所有报告都将通过互联网进行。在此背景下,与其他系统相比,SmiNet-2 的一些主要优势包括数据流的及时性(达到国家一级)、临床和实验室通知的全面整合,以及能够在一个系统内通过定制的通知表格处理 50 多种疾病。
Electronic systems for communicable diseases surveillance enhance quality by simplifying reporting, improving completeness, and increasing timeliness. In this article we outline the ideas and technologies behind SmiNet-2, a new comprehensive regional/national system for communicable disease surveillance in Sweden. The system allows for reporting from physicians (web form) and laboratories (direct from lab data system) over the internet. Using a unique personal identification number, SmiNet-2 automatically merges clinical and laboratory notifications to case records. Privileged users, at national and county level, work against a common central server containing all notifications and case records. In addition, SmiNet-2 has separate county servers with tools for outbreak investigations, contact tracing and case management. SmiNet-2 was first used in September 2004. Individual counties receive up to 90% of all notifications electronically. In its first year, SmiNet-2 received 54 980 clinical notifications and 32,765 laboratory notifications, which generated 58,891 case records. Since most clinicians in Sweden have easy access to the internet, a general web-based reporting has been feasible, and it is anticipated that within a few years all reporting to SmiNet-2 will be over the internet. In this context, some of the major advantages of SmiNet-2 when compared with other systems are timeliness in the dataflow (up to national level), the full integration of clinical and laboratory notifications, and the capability to handle more than 50 diseases with tailor-made notification forms within one single system.Electronic systems for communicable diseases surveillance enhance quality by simplifying reporting, improving completeness, and increasing timeliness. In this article we outline the ideas and technologies behind SmiNet-2, a new comprehensive regional/national system for communicable disease surveillance in Sweden. The system allows for reporting from physicians (web form) and laboratories (direct from lab data system) over the internet. Using a unique personal identification number, SmiNet-2 automatically merges clinical and laboratory notifications to case records. Privileged users, at national and county level, work against a common central server containing all notifications and case records. In addition, SmiNet-2 has separate county servers with tools for outbreak investigations, contact tracing and case management. SmiNet-2 was first used in September 2004. Individual counties receive up to 90% of all notifications electronically. In its first year, SmiNet-2 received 54 980 clinical notifications and 32 765 laboratory notifications, which generated 58 891 case records. Since most clinicians in Sweden have easy access to the internet, a general web-based reporting has been feasible, and it is anticipated that within a few years all reporting to SmiNet-2 will be over the internet. In this context, some of the major advantages of SmiNet-2 when compared with other systems are timeliness in the dataflow (up to national level), the full integration of clinical and laboratory notifications, and the capability to handle more than 50 diseases with tailor-made notification forms within one single system.